An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock.
Induction of anaphylactic shock in mice by i.v. antigen challenge (bovine serum albumin, 100 micrograms) or i.v. treatment with the mast cell degranulator compound 48/80 resulted in 80 and 90% mortality rate, respectively. Inhibition of nitric oxide (NO) synthesis from L-arginine by co-injection of the L-arginine analog NG-nitro-L-arginine methyl ester (L-NAME, 30 mg/kg) reduced the mortality rate by 40 and 20% in the antigen- and compound 48/80-induced shock models. Treatment with 60 mg/kg L-NAME reduced the mortality rate by 60% in these shock models. This beneficial effect was reversed by addition of L-arginine (120 mg/kg) but not D-arginine (120 mg/kg). These results suggest NO production as a possible mechanism involved in the pathophysiology of anaphylactic shock.
Amir
S
S
Centre for Studies in Behavioral Neurobiology, Concordia University, Montreal, Canada.
English
A M
AM
D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000187:drug effects / Q000648:ultrastructure; D007275:Injections, Intravenous; D008407:Mast Cells / Q000187:drug effects / Q000648:ultrastructure; D051379:Mice; D019331:NG-Nitroarginine Methyl Ester; D009569:Nitric Oxide / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000276:immunology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D012710:Serum Albumin, Bovine; D009569:Nitric Oxide; D003189:p-Methoxy-N-methylphenethylamine; D001120:Arginine; D019331:NG-Nitroarginine Methyl Ester